Characteristics of the Patients Aged Less than 40 Years Operated for a Renal Mass

Main Article Content

Abdullah Ilktac
Bayram Dogan
Cevper Ersoz
Ganime Coban
Senad Kalkan

Keywords

benign renal neoplasm, hereditary renal cell carcinoma, kidney tumor, renal cell carcinoma, young adults

Abstract

The incidence of renal cell cancer (RCC) is low in individuals aged less than 40 years; however several studies have shown this increasing trend over the years. Hereditary syndromes are associated with RCC and are more frequently observed in early-onset cases. In this study, we investigated the characteristics of the patients, aged less than 40 years, who were operated for a renal mass with the suspicion of RCC. We analyzed patients aged <40 years who underwent partial or radical nephrectomy between January 2012 and December 2022. A total of 618 patients underwent partial or radical nephrectomy and 60 (9.7%) patients were aged <40 years. A total of 62 renal masses were resected. The median age of the patients was 34 (31.75–38) years. RCC was detected in 50 (80.6%) lesions, while 12 (19.4%) lesions were benign. The most commonly observed benign tumors were oncocytoma and multicystic nephroma. Low-stage RCC (stage 1) was detected in 78% of patients. Recurrence was observed in two patients and both had von Hippel–Landau gene mutation. During follow-up, two patients were found to have lung metastasis, while another patient had bone metastasis. Three patients died during the follow-up period. Disease free survival rate was 89.58% and cancer specific survival rate was 93.88%. The incidences of kidney cancer in young adults are increasing; therefore, early discovery and the diagnosis are important. Further research is required to gain a better understanding.

Abstract 351 | PDF Downloads 556 HTML Downloads 0 XML Downloads 3

References

1. Bukavina L, Bensalah K, Bray F, Carlo M, Challacombe B, Karam JA, et al. Epidemiology of renal cell carcinoma: 2022 Update. Eur Urol. 2022 Nov;82(5):529–42. 10.1016/j.eururo.2022.08.019

2. Znaor A, Lortet-Tieulent J, Jemal A, Bray F. International variations and trends in testicular cancer incidence and mortality. Eur Urol. 2014;65(6):1095–106. 10.1016/j.eururo.2013.11.004

3. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023 Jan 73(1):17–48. 10.3322/caac.21763

4. Palumbo C, Pecoraro A, Rosiello G, Luzzago S, Deuker M, Stolzenbach F, et al. Renal cell carcinoma incidence rates and trends in young adults aged 20–39 years. Cancer Epidemiol. 2020 Aug;67:101762. 10.1016/j.canep.2020.101762

5. Kang HW, Seo SP, Kim WT, Yun SJ, Lee SC, Kim WJ, et al. Impact of young age at diagnosis on survival in patients with surgically treated renal cell carcinoma: A multicenter study. J Korean Med Sci. 2016 Dec;31(12):1976–82. 10.3346/jkms.2016.31.12.1976

6. Gillett MD, Cheville JC, Karnes RJ, Lohse CM, Kwon ED, Leibovich BC, et al. Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses. J Urol. 2005 Jun;173(6):1893–6. 10.1097/01.ju.0000158157.57981.80

7. Shuch B, Vourganti S, Ricketts CJ, Middleton L, Peterson J, Merino MJ, et al. Defining early-onset kidney cancer: Implications for germline and somatic mutation testing and clinical management. J Clin Oncol. 2014 Feb;32(5):431–7. 10.1200/JCO.2013.50.8192

8. Kehm RD, Yang W, Tehranifar P, Terry MB. 40 years of change in age-and stage-specific cancer incidence rates in US women and men. JNCI Cancer Spectr. 2019 Sep;3(3):pkz038. 10.1093/jncics/pkz038

9. Fidler MM, Gupta S, Soerjomataram I, Ferlay J, Steliarova-Foucher E, Bray F. Cancer incidence and mortality among young adults aged 20–39 years worldwide in 2012: A population-based study. Lancet Oncol. 2017 Dec;18(12):1579–89. 10.1016/S1470-2045(17)30677-0

10. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: A need to reassess treatment effect. J Natl Cancer Inst. 2006 Sep;98(18):1331–4. 10.1093/jnci/djj362

11. Volpe A, Panzarella T, Rendon RA, Haider MA, Kondylis FI, Jewett MAS. The natural history of incidentally detected small renal masses. Cancer. 2004 Feb;100(4):738–45. 10.1002/cncr.20025

12. Hindman N, Ngo L, Genega EM, Melamed J, Wei J, Braza JM, et al. Angiomyolipoma with minimal fat: Can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques? Radiology. 2012 Nov;265(2):468–77. 10.1148/radiol.12112087

13. Choudhary S, Rajesh A, Mayer NJ, Mulcahy KA, Haroon A. Renal oncocytoma: CT features cannot reliably distinguish oncocytoma from other renal neoplasms. Clin Radiol. 2009 May;64(5):517–22. 10.1016/j.crad.2008.12.011

14. Rosenkrantz AB, Hindman N, Fitzgerald EF, Niver BE, Melamed J, Babb JS. MRI features of renal oncocytoma and chromophobe renal cell carcinoma. AJR Am J Roentgenol. 2010 Dec;195(6):W421–7. 10.2214/AJR.10.4718

15. Bauman TM, Potretzke AM, Wright AJ, Knight BA, Vetter JM, Figenshau RS. Partial nephrectomy for presumed renal-cell carcinoma: Incidence, predictors, and perioperative outcomes of benign lesions. J Endourol. 2017 Apr;31(4):412–7. 10.1089/end.2016.0667

16. Silverman SG, Pedrosa I, Ellis JH, Hindman NM, Schieda N, Smith AD, et al. Bosniak classification of cystic renal masses, version 2019: An update proposal and needs assessment. Radiology. 2019 Aug;292(2):475–88. 10.1148/radiol.2019182646

17. Tse JR, Shen L, Shen J, Yoon L, Kamaya A. Prevalence of malignancy and histopathological association of Bosniak classification, version 2019 class III and IV cystic renal masses. J Urol. 2021 Apr;205(4):1031–8. 10.1097/JU.0000000000001438

18. Brierley, JD., Gospodarowicz, Mary K, Wittenkind C. TNM classification of malignant tumours, 8th ed. Published in affiliation with the Union for International Cancer Control (UICC). Hoboken, NJ: Wiley-Blackwell; 2017; 272 p. 10.1002/9780471420194.tnmc26.pub3

19. Ljungberg B, Albiges L, Abu-Ghanem Y, Bedke J, Capitanio U, Dabestani S, et al. European Association of Urology guidelines on renal cell carcinoma: The 2022 update. Eur Urol. 2022 Oct;82(4):399–410. 10.1016/j.eururo.2022.03.006

20. Yıkılmaz TN, Bas¸ O, Arık, Aİ., Hızlı F, Bas¸ar H. The relationship between histopathology and age factor in patients who were operated for renal masses. Turkish J Urol. 2015 Jun;41(2):57–60. 10.5152/tud.2015.54521

21. Douglas B, Davaro F, May A, Siddiqui S, Hamilton Z. Clinical characteristics of renal cell carcinoma in patients under the age of 40. Urol Oncol. 2021 Jul;39(7):438.e23–30. 10.1016/j.urolonc.2021.04.008

22. Vogel C, Ziegelmüller B, Ljungberg B, Bensalah K, Bex A, Canfield S, et al. Imaging in suspected renal-cell carcinoma: Systematic review. Clin Genitourin Cancer. 2019 Apr;17(2):e345–55. 10.1016/j.clgc.2018.07.024

23. Baio R, Molisso G, Caruana C, Di Mauro U, Intilla O, Pane U, et al. “To be or not to be benign” at partial nephrectomy for presumed RCC renal masses: Single-center experience with 195 consecutive patients. Diseases (Basel, Switzerland). 2023 Feb 11(1):27. 10.3390/diseases11010027

24. Thompson RH, Ordonez MA, Iasonos A, Secin FP, Guillonneau B, Russo P, et al. Renal cell carcinoma in young and old patients—Is there a difference? J Urol. 2008 Oct;180(4):1262–6; discussion 1266. 10.1016/j.juro.2008.06.037

25. Bhindi B, Thompson RH, Lohse CM, Mason RJ, Frank I, Costello BA, et al. The probability of aggressive versus indolent histology based on renal tumor size: Implications for surveillance and treatment. Eur Urol. 2018 Oct;74(4):489–97. 10.1016/j.eururo.2018.06.003

26. Aslan R, Taken K, Eryılmaz R. Clinicopathological features and survival data of localized renal masses in young adults. Asian Pac J Cancer Prev. 2018 Nov;19(11):3233–6. 10.31557/APJCP.2018.19.11.3233

27. Richard PO, Jewett MAS, Bhatt JR, Kachura JR, Evans AJ, Zlotta AR, et al. Renal tumor biopsy for small renal masses: A single-center 13-year experience. Eur Urol. 2015 Dec;68(6):1007–13. 10.1016/j.eururo.2015.04.004

28. Huang X, Griffin B, Lin X. Management of patients with renal mass lesions based on renal biopsy cytology results. Hum Pathol. 2019 Mar;85:270–8. 10.1016/j.humpath.2018.11.010

29. Marconi L, Dabestani S, Lam TB, Hofmann F, Stewart F, Norrie J, et al. Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal tumour biopsy. Eur Urol. 2016 Apr;69(4):660–73. 10.1016/j.eururo.2015.07.072

30. Couture F, Finelli T, Breau RH, Mallick R, Bhindi B, Tanguay S, et al. The increasing use of renal tumor biopsy amongst Canadian urologists: When is biopsy most utilized? Urol Oncol. 2021 Aug;39(8):499.e15–22. 10.1016/j.urolonc.2021.05.026

31. Aziz A, May M, Zigeuner R, Pichler M, Chromecki T, Cindolo L, et al. Do young patients with renal cell carcinoma feature a distinct outcome after surgery? A comparative analysis of patient age based on the multinational CORONA database. J Urol. 2014 Feb;191(2):310–5. 10.1016/j.juro.2013.08.021

32. Taccoen X, Valeri A, Descotes J-L, Morin V, Stindel E, Doucet L, et al. Renal cell carcinoma in adults 40 years old or less: Young age is an independent prognostic factor for cancer-specific survival. Eur Urol. 2007 Apr;51(4):980–7. 10.1016/j.eururo.2006.10.025

33. Pierorazio PM, Patel HD, Johnson MH, Sozio SM, Sharma R, Iyoha E, et al. Distinguishing malignant and benign renal masses with composite models and nomograms: A systematic review and meta-analysis of clinically localized renal masses suspicious for malignancy. Cancer. 2016 Nov;122(21):3267–76. 10.1002/cncr.30268

34. Linehan WM, Rathmell WK. Kidney cancer. Urol Oncol. 2012;30(6):948–51. 10.1016/j.urolonc.2012.08.021

35. Xiong L, Chen X, Liu N, Wang Z, Miao B, Gan W, et al. PRCC-TFE3 dual-fusion FISH assay: A new method for identifying PRCC-TFE3 renal cell carcinoma in paraffin-embedded tissue. PLoS One. 2017;12(9):e0185337. 10.1371/journal.pone.0185337

36. Classe M, Malouf GG, Su X, Yao H, Thompson EJ, Doss DJ, et al. Incidence, clinicopathological features and fusion transcript landscape of translocation renal cell carcinomas. Histopathology. 2017 Jun;70(7):1089–97. 10.1111/his.13167

37. Gill AJ, Hes O, Papathomas T, Šedivcová M, Tan PH, Agaimy A, et al. Succinate dehydrogenase (SDH)-deficient renal carcinoma: A morphologically distinct entity: A clinicopathologic series of 36 tumors from 27 patients. Am J Surg Pathol. 2014 Dec;38(12):1588–602. 10.1097/PAS.0000000000000292